YOLFTbeta
Pulsenmore Ltd. Ordinary Shares

Pulsenmore Ltd. Ordinary Shares

PLSM · NASDAQ · Healthcare / Medical Devices

1.38USD-0.09 (-6.12%)

Price History

Full chart

Market Stats

Previous Close1.47
Open1.46
Day Range1.38 – 1.48
52-Week Range2.22 – 2,226.00
Volume12.94K
Market Cap15.67M
P/E (TTM)0.00
Forward P/E0.00
EPS-1.39
Dividend Yield0.00%
Beta0.40
50-Day Avg2.95
200-Day Avg4.00

About

Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe. The company was incorporated in 2014 and is based in Omer, Israel.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Elazar Sonnenschein
  • Employees71
  • Headquarters8 Omarim Street, Omer, Israel, USA
  • Websitehttps://www.pulsenmore.com

Leadership

  • Dr. Elazar SonnenscheinFounder, CEO & Director · b. 1963
  • Mr. Eran HirshChief Financial Officer · b. 1977
  • Mr. Minelu SonnenscheinVice President of R&D · b. 1965
  • Mr. Meir ShmouelyVice President of Software Development · b. 1966
  • Mr. Michael HamelsdorfGeneral Counsel & Company Secretary · b. 1980
  • Ms. Mira Altmark-SoferVice President of Marketing · b. 1977
  • Prof. Israel MeiznerChief Medical Officer & Member of Scientific Advisory Committee

Financials

Income Statement

Currency: ILS2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--1.58M10.59M6.14M9.64M40.02M
Growth (%)---+571.73%-42.08%+57.11%+315.22%
Cost of Revenue242.65K350.21K1.37M6.72M6.10M7.57M6.34M
Gross Profit-242.65K-350.21K206.84K3.87M39.66K2.07M33.68M
Gross Margin--13.12%36.55%0.65%21.43%84.15%
Operating Expense3.94M12.93M22.13M49.12M55.15M44.18M45.85M
Operating Income-4.18M-13.28M-21.92M-45.25M-55.11M-42.12M-12.16M
Operating Margin---1390.24%-427.24%-898.29%-436.96%-30.39%
EBITDA-4.31M-13.30M-24.76M-20.05M-54.95M-33.32M-12.73M
EBITDA Margin---1570.09%-189.33%-895.72%-345.72%-31.81%
Net Income-4.64M-13.75M-25.61M-21.66M-58.07M-36.65M-15.85M
Net Income Margin---1623.89%-204.54%-946.46%-380.25%-39.61%
R&D2.74M10.29M10.61M28.28M30.07M18.87M17.35M
R&D as % of Total Revenue--672.69%266.95%490.05%195.73%43.35%
Interest Expense82.29K95.06K288.78K341.83K605.78K538.78K315.00K
Interest Expense % of Total Revenue--18.31%3.23%9.87%5.59%0.79%

Balance Sheet

Currency: ILS2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets6.32M9.01M167.04M231.45M178.37M141.50M101.85M
Total Liabilities2.37M3.74M7.76M48.79M47.68M38.35M18.76M
Total Equity3.95M2.89M153.62M183.67M131.10M96.67M83.09M
Cash4.87M6.13M112.92M15.19M23.80M41.22M21.60M
Total Debt2.12M1.08M1.02M6.92M5.69M3.23M1.56M
Net Debt-2.75M-5.05M-111.90M-8.27M-18.12M-37.98M-20.04M

Cash Flow

Currency: ILS2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.83M-9.47M-26.01M-24.51M-42.45M-33.71M-32.88M
Investing Cash Flow-185.68K-389.23K-41.22M-297.70M49.43M50.79M13.85M
Financing Cash Flow8.91M11.86M178.31M49.92M-1.13M-1.56M4.00K
Capital Expenditure185.68K389.23K774.42K4.41M3.89M507.85K135.00K
Free Cash Flow-4.01M-9.85M-26.79M-28.92M-46.34M-34.22M-33.01M
Dividends Paid---0000
FCF to OCF104.85%104.11%102.98%118.01%109.17%101.51%100.41%
Dividend Paid to FCF---0.00%0.00%0.00%0.00%

Key Statistics & Ratios

Market Cap15.67M
Enterprise Value-7.06M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.10
Price / Book0.97
EPS-1.39
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-10.38M
Profit Margin-65.95%
Operating Margin0.00%
Return on Equity-45.21%
Return on Assets-6.98%
Shares Outstanding6.50M
Shares Float3.21M
Beta0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
5.57%
Insiders
43.40%
Retail / Other
51.03%

Top Fund Holders

  • Fidelity Nasdaq Composite Index
    2.40K0.04%